March 02, 2020
Generic-drug makers Hetero and Zydus have each reached last-minute settlements to avoid an infringement trial set for Monday over their versions of Novartis Pharmaceuticals Corp.'s blockbuster multiple sclerosis drug Gilenya.
January 29, 2020
Immediately after Novartis was granted a new patent Tuesday, the pharma giant sued a large group of generic-drug makers hoping to block their competing versions of its $3 billion multiple sclerosis drug Gilenya.